Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases.

Memon AB, Javed A, Caon C, Srivastawa S, Bao F, Bernitsas E, Chorostecki J, Tselis A, Seraji-Bozorgzad N, Khan O.

PLoS One. 2018 Jan 8;13(1):e0190425. doi: 10.1371/journal.pone.0190425. eCollection 2018.

2.

Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis.

Bernitsas E, Khan O, Razmjou S, Tselis A, Bao F, Caon C, Millis S, Seraji-Bozorgzad N.

PLoS One. 2017 Jul 20;12(7):e0181431. doi: 10.1371/journal.pone.0181431. eCollection 2017.

3.

Cerebral Gray Matter Atrophy Is Associated with the CSF IgG index in African American with Multiple Sclerosis.

Seraji-Bozorgzad N, Khan O, Cree BAC, Bao F, Caon C, Zak I, Razmjou S, Tselis A, Millis S, Bernitsas E.

J Neuroimaging. 2017 Sep;27(5):476-480. doi: 10.1111/jon.12435. Epub 2017 Mar 29.

PMID:
28371088
4.

Bilateral cisternal abducens nerve involvement with ophthalmoplegic migraine.

Tripathi R, Tselis A, Bernitsas E.

Cephalalgia. 2017 Oct;37(12):1211-1212. doi: 10.1177/0333102416681569. Epub 2016 Nov 24. No abstract available.

PMID:
27881687
5.

Characterizing retinal structure injury in African-Americans with multiple sclerosis.

Seraji-Bozorgzad N, Reed S, Bao F, Santiago C, Tselis A, Bernitsas E, Caon C, Frohman E, Bhatti MT, Cree BA, Khan O.

Mult Scler Relat Disord. 2016 May;7:16-20. doi: 10.1016/j.msard.2016.02.009. Epub 2016 Feb 12.

PMID:
27237751
6.

Sacral Spine Myeloid Sarcoma.

Dhakar MB, Bansal P, Tselis AC.

Neurohospitalist. 2016 Apr;6(2):87-8. doi: 10.1177/1941874415599578. Epub 2015 Aug 12. No abstract available.

7.

A Cryptic Case: Isolated Cerebral Mucormycosis.

Dhakar MB, Rayes M, Kupsky W, Tselis A, Norris G.

Am J Med. 2015 Dec;128(12):1296-9. doi: 10.1016/j.amjmed.2015.08.033. Epub 2015 Oct 9. No abstract available.

PMID:
26450170
8.

Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes.

Bernitsas E, Bao F, Seraji-Bozorgzad N, Chorostecki J, Santiago C, Tselis A, Caon C, Zak I, Millis S, Khan O.

Mult Scler Relat Disord. 2015 Jan;4(1):47-51. doi: 10.1016/j.msard.2014.11.002. Epub 2014 Nov 18.

PMID:
25787052
9.

Preface.

Tselis AC, Booss J.

Handb Clin Neurol. 2014;123:ix-x. doi: 10.1016/B978-0-444-53488-0.09984-3. No abstract available.

PMID:
25015517
10.

Cytomegalovirus infections of the adult human nervous system.

Tselis AC.

Handb Clin Neurol. 2014;123:307-18. doi: 10.1016/B978-0-444-53488-0.00014-6. No abstract available.

PMID:
25015492
11.

Epstein-Barr virus infections of the nervous system.

Tselis AC.

Handb Clin Neurol. 2014;123:285-305. doi: 10.1016/B978-0-444-53488-0.00013-4. Review. No abstract available.

PMID:
25015491
12.

A history of viral infections of the central nervous system: foundations, milestones, and patterns.

Booss J, Tselis AC.

Handb Clin Neurol. 2014;123:3-44. doi: 10.1016/B978-0-444-53488-0.00001-8. Review. No abstract available.

PMID:
25015479
13.

Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4.

Figueroa M, Guo Y, Tselis A, Pittock SJ, Lennon VA, Lucchinetti CF, Lisak RP.

JAMA Neurol. 2014 Apr;71(4):495-8. doi: 10.1001/jamaneurol.2013.6331.

14.

Non-lyme tick-borne diseases: a neurological perspective.

Seraji-Bozorgzad N, Tselis AC.

Curr Neurol Neurosci Rep. 2013 Oct;13(10):388. doi: 10.1007/s11910-013-0388-6. Review.

PMID:
24014177
15.

Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.

Sundal C, Fujioka S, Van Gerpen JA, Wider C, Nicholson AM, Baker M, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Tselis A, Swerdlow RH, Miller BB, Borjesson-Hanson A, Uitti RJ, Ross OA, Stoessl AJ, Rademakers R, Josephs KA, Dickson DW, Broderick D, Wszolek ZK.

Parkinsonism Relat Disord. 2013 Oct;19(10):869-77. doi: 10.1016/j.parkreldis.2013.05.013. Epub 2013 Jun 17.

16.

MRI characteristics and scoring in HDLS due to CSF1R gene mutations.

Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, Broderick D, Wszolek ZK.

Neurology. 2012 Aug 7;79(6):566-74. doi: 10.1212/WNL.0b013e318263575a. Epub 2012 Jul 25.

17.

Epstein-Barr virus cause of multiple sclerosis.

Tselis A.

Curr Opin Rheumatol. 2012 Jul;24(4):424-8. doi: 10.1097/BOR.0b013e3283542cf8. Review.

PMID:
22617821
18.

Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.

Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cairns NJ, Ghetti B, Spina S, Garbern J, Tselis AC, Uitti R, Das P, Van Gerpen JA, Meschia JF, Levy S, Broderick DF, Graff-Radford N, Ross OA, Miller BB, Swerdlow RH, Dickson DW, Wszolek ZK.

Nat Genet. 2011 Dec 25;44(2):200-5. doi: 10.1038/ng.1027.

19.

Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity.

Sundal C, Lash J, Aasly J, Ƙygarden S, Roeber S, Kretzschman H, Garbern JY, Tselis A, Rademakers R, Dickson DW, Broderick D, Wszolek ZK.

J Neurol Sci. 2012 Mar 15;314(1-2):130-7. doi: 10.1016/j.jns.2011.10.006. Epub 2011 Nov 1.

20.

Evidence for viral etiology of multiple sclerosis.

Tselis A.

Semin Neurol. 2011 Jul;31(3):307-16. doi: 10.1055/s-0031-1287656. Epub 2011 Sep 30. Review.

PMID:
21964847
21.

Effect of disease-modifying therapies on brain volume in relapsing-remitting multiple sclerosis: results of a five-year brain MRI study.

Khan O, Bao F, Shah M, Caon C, Tselis A, Bailey R, Silverman B, Zak I.

J Neurol Sci. 2012 Jan 15;312(1-2):7-12. doi: 10.1016/j.jns.2011.08.034. Epub 2011 Sep 13.

PMID:
21920559
22.

Primary intracranial plasma cell granulomas presenting as malignant neoplasms.

Puntambekar P, Santhakumar S, Kupsky WJ, Tselis A, Mittal S.

J Neurooncol. 2012 Jan;106(2):327-37. doi: 10.1007/s11060-011-0667-5. Epub 2011 Jul 24.

PMID:
21786175
23.

Leber hereditary optic neuropathy mimicking neuromyelitis optica.

McClelland CM, Van Stavern GP, Tselis AC.

J Neuroophthalmol. 2011 Sep;31(3):265-8. doi: 10.1097/WNO.0b013e318225247b. Review.

PMID:
21734595
24.

Chronic cerebrospinal venous insufficiency and multiple sclerosis: science or science fiction?

Khan O, Tselis A.

J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):355. doi: 10.1136/jnnp.2010.228098. No abstract available.

PMID:
21406538
25.

Getting to grips with myelin injury in progressive multiple sclerosis.

Khan O, Tselis A, Lisak R.

Brain. 2010 Oct;133(10):2845-8. doi: 10.1093/brain/awq271. Epub 2010 Sep 24. No abstract available.

PMID:
20870778
26.

Approaches to neuroprotective strategies in multiple sclerosis.

Tselis A, Khan OA, Lisak RP.

Expert Opin Pharmacother. 2010 Dec;11(17):2869-78. doi: 10.1517/14656566.2010.508070. Epub 2010 Aug 5. Review.

PMID:
20687779
27.

Onset of vulvodynia in a woman ultimately diagnosed with Creutzfeldt-Jakob disease.

Reichman O, Tselis A, Kupsky WJ, Sobel JD.

Obstet Gynecol. 2010 Feb;115(2 Pt 2):423-5. doi: 10.1097/AOG.0b013e3181b80294.

PMID:
20093867
28.
29.

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.

Khan OA, Tselis A, Boster A.

Neurology. 2009 Jun 16;72(24):2134; author reply 2134-5. doi: 10.1212/01.wnl.0000349656.65459.5f. No abstract available.

PMID:
19528523
30.

Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.

Boster A, Hreha S, Berger JR, Bao F, Penmesta R, Tselis A, Endress C, Zak I, Perumal J, Caon C, Vazquez J, Tyler KL, Racke MK, Millis S, Khan O.

Arch Neurol. 2009 May;66(5):593-9. doi: 10.1001/archneurol.2009.31.

PMID:
19433659
31.

Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin.

Tselis A, Perumal J, Caon C, Hreha S, Ching W, Din M, Van Stavern G, Khan O.

Eur J Neurol. 2008 Nov;15(11):1163-7. doi: 10.1111/j.1468-1331.2008.02258.x. Epub 2008 Aug 21.

PMID:
18727675
32.

Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence.

Boster A, Caon C, Perumal J, Hreha S, Zabad R, Zak I, Tselis A, Lisak R, Khan O.

Mult Scler. 2008 Jul;14(6):804-8. doi: 10.1177/1352458507088156. Epub 2008 Jun 23.

PMID:
18573830
33.

Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.

Perumal JS, Caon C, Hreha S, Zabad R, Tselis A, Lisak R, Khan O.

Eur J Neurol. 2008 Jul;15(7):677-80. doi: 10.1111/j.1468-1331.2008.02146.x. Epub 2008 May 6.

PMID:
18459972
34.

Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.

Khan O, Shen Y, Bao F, Caon C, Tselis A, Latif Z, Zak I.

J Neuroimaging. 2008 Jul;18(3):314-9. doi: 10.1111/j.1552-6569.2007.00206.x.

PMID:
18304034
35.

Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician.

Boster A, Edan G, Frohman E, Javed A, Stuve O, Tselis A, Weiner H, Weinstock-Guttman B, Khan O; Multiple Sclerosis Clinical Research Center, Department of Neurology, Wayne State University School of Medicine.

Lancet Neurol. 2008 Feb;7(2):173-83. doi: 10.1016/S1474-4422(08)70020-6. Review.

PMID:
18207115
36.

Acute transverse myelitis with normal brain MRI : long-term risk of MS.

Perumal J, Zabad R, Caon C, MacKenzie M, Tselis A, Bao F, Latif Z, Zak I, Lisak R, Khan O.

J Neurol. 2008 Jan;255(1):89-93. Epub 2007 Dec 20.

PMID:
18080852
37.

HIV-related peripheral neuropathy and glucose dysmetabolism: study of a public dataset.

Sheth SG, Rao CV, Tselis A, Lewis RA.

Neuroepidemiology. 2007;29(1-2):121-4. Epub 2007 Oct 16.

PMID:
17940344
38.

Management of isolated demyelinating episodes by North American neurologists.

Tselis A, Chaturvedi S, Borsody M, Vaidya R.

Can J Neurol Sci. 2007 Aug;34(3):375-6. No abstract available.

PMID:
17803042
39.

Glatiramer acetate in the treatment of multiple sclerosis.

Tselis A, Khan O, Lisak RP.

Neuropsychiatr Dis Treat. 2007 Apr;3(2):259-67.

40.

Glatiramer acetate therapy for multiple sclerosis: a review.

Perumal J, Filippi M, Ford C, Johnson K, Lisak R, Metz L, Tselis A, Tullman M, Khan O.

Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):1019-29. Review.

PMID:
17125414
41.

Clinical course after change of immunomodulating therapy in relapsing-remitting multiple sclerosis.

Caon C, Din M, Ching W, Tselis A, Lisak R, Khan O.

Eur J Neurol. 2006 May;13(5):471-4.

PMID:
16722971
42.

Other demyelinating diseases.

Tselis AC, Lisak RP.

Adv Neurol. 2006;98:335-49. Review. No abstract available.

PMID:
16400843
43.

Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis.

Khan O, Shen Y, Caon C, Bao F, Ching W, Reznar M, Buccheister A, Hu J, Latif Z, Tselis A, Lisak R.

Mult Scler. 2005 Dec;11(6):646-51.

PMID:
16320723
44.

A case of Hashimoto's encephalopathy: association with sensory ganglionopathy.

Cao NJ, Tselis AC, Li J, Gorman M.

J Neurol Sci. 2005 Nov 15;238(1-2):105-7. Epub 2005 Aug 31.

PMID:
16139308
45.
46.

Behavioral consequences of infections of the central nervous system: with emphasis on viral infections.

Tselis A, Booss J.

J Am Acad Psychiatry Law. 2003;31(3):289-98. Review.

PMID:
14584527
47.

Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection.

Li J, Loeb JA, Shy ME, Shah AK, Tselis AC, Kupski WJ, Lewis RA.

Ann Neurol. 2003 Jun;53(6):703-10.

PMID:
12783415
48.

Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis.

Caon C, Zvartau-Hind M, Ching W, Lisak RP, Tselis AC, Khan OA.

Neurology. 2003 Jan 28;60(2):323-5.

PMID:
12552053
49.

Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis.

Khan O, Zabad R, Caon C, Zvartau-Hind M, Tselis A, Lisak R.

CNS Drugs. 2002;16(8):563-78. Review.

PMID:
12096936
50.

Glatiramer acetate for multiple sclerosis: a comprehensive review of mechanisms and clinical efficacy.

Zvartau-Hind M, Caon C, Zabad R, Tselis A, Lisak R, Khan O.

Expert Rev Neurother. 2002 May;2(3):285-94. doi: 10.1586/14737175.2.3.285.

PMID:
19810859

Supplemental Content

Loading ...
Support Center